Skip to main content
Erschienen in: Wiener Medizinische Wochenschrift 1-2/2013

01.01.2013 | review

Onychomycosis: modern diagnostic and treatment approaches

verfasst von: Assoc. Prof. Georgi Tchernev, Plamen Kolev Penev, MD, Prof. Dr. med. Pietro Nenoff, Assoc. Prof. Liliya Georgieva Zisova, MD, PhD, José Carlos Cardoso, Dr. Teodora Taneva, Assoc. Prof. Gabriele Ginter-Hanselmayer, MD, Julian Ananiev, Assoc. Prof. Maya Gulubova, MD, PhD, Reni Hristova, MD, Desislava Nocheva, MD, Claudio Guarneri, MD, A.O.U. G. Martino, Nobuo Kanazawa, MD, PhD

Erschienen in: Wiener Medizinische Wochenschrift | Ausgabe 1-2/2013

Einloggen, um Zugang zu erhalten

Summary

The medical term onychomycosis should be understood as chronic infection of the nails caused by a fungus. The most common causative agents are the dermatophytes and Candida species. The less common are certain types of moulds (nondermatophyte moulds or NDMs). In approximately 60–80 % of the cases, onychomycosis is due to dermatophytes. Among dermatophytes, the most often isolated causative pathogen is Trichophyton (T.) rubrum. Other common species are T. interdigitale (formerly T. mentagrophytes), Epidermophyton floccosum, and T. tonsurans. The most significant yeasts causing onychomycosis are Candida albicans and Candida parapsilosis. Predisposing factors for onychomycosis include mainly diseases such as diabetes mellitus, peripheral vascular arterial disease, chronic venous insufficiency, polyneuropathies of diverse etiologies, and immunosuppression, e.g., myeloproliferative diseases (such as lymphoma and paraproteinemia), HIV/AIDS, etc. Other factors facilitating the fungal infection are frequent trauma in professional sportsmen, often accompanied by excessive perspiration. The diagnostic methods that are often applied in different dermatologic departments and ambulatory units are also different. This precludes the creation of a unified diagnostic algorithm that could be used everywhere as a possible standard. In most of the cases, the method of choice depends on the specialist’s individual experience. The therapeutic approach depends mostly on the fungal organism identified by the dermatologist or mycologist. This review hereby includes the conventional as well as the newest and most reliable and modern methods used for the identification of the pathogens causing onychomycosis. Moreover, detailed information is suggested, about the choice of therapeutic scheme in case whether dermatophytes, moulds, or yeasts have been identified as causative agents. A thorough discussion of the schemes and duration of the antifungal therapy in certain groups of patients have been included.
Literatur
1.
Zurück zum Zitat Gupta AK, Jain HC, Lynde CW. Prevalence and epidemiology of onychomycosis in patients visiting physicians’ offices: a multicenter Canadian survey of 15,000 patients. J Am Acad Dermatol. 2000;43:244–8.CrossRefPubMed Gupta AK, Jain HC, Lynde CW. Prevalence and epidemiology of onychomycosis in patients visiting physicians’ offices: a multicenter Canadian survey of 15,000 patients. J Am Acad Dermatol. 2000;43:244–8.CrossRefPubMed
2.
Zurück zum Zitat Ghannoum MA, Hajjeh RA, Scher R, Konnikov N, Gupta AK, Summerbell R et al. A large scale North American study of fungal isolated from nails; the frequency of onychomycosis, fungal distribution, and antifungal susceptibility patterns. J Am Acad Dermatol. 2000;43:641–8.CrossRefPubMed Ghannoum MA, Hajjeh RA, Scher R, Konnikov N, Gupta AK, Summerbell R et al. A large scale North American study of fungal isolated from nails; the frequency of onychomycosis, fungal distribution, and antifungal susceptibility patterns. J Am Acad Dermatol. 2000;43:641–8.CrossRefPubMed
3.
Zurück zum Zitat Hamnerius N, Berglund J, Faergemann J. Pedal dermatophyte infection in psoriasis. Br J Dermatol. 2004;150:1125–8.CrossRefPubMed Hamnerius N, Berglund J, Faergemann J. Pedal dermatophyte infection in psoriasis. Br J Dermatol. 2004;150:1125–8.CrossRefPubMed
4.
Zurück zum Zitat Burzykowski T, Molenberghs G, Abeck D, et al. High prevalence of foot disease in Europe; results of the Ahilese project. Mycoses. 2003;46:496–505.CrossRefPubMed Burzykowski T, Molenberghs G, Abeck D, et al. High prevalence of foot disease in Europe; results of the Ahilese project. Mycoses. 2003;46:496–505.CrossRefPubMed
5.
Zurück zum Zitat Wolff K, Johnson RA, Suurmond D. Fitzpatrick’s color atlas and synopsis of clinical dermatology. 5th ed. New York: McGraw Hill; 2005. p. 1004. Wolff K, Johnson RA, Suurmond D. Fitzpatrick’s color atlas and synopsis of clinical dermatology. 5th ed. New York: McGraw Hill; 2005. p. 1004.
6.
Zurück zum Zitat Shemer A, Nathansohn N, Kaplan B, Trau H. Toenail abnormalities and onychomycosis in chronic venous insufficiency of the legs: should we treat? J Eur Acad Dermatol Venereol. 2008;22:279–82.CrossRefPubMed Shemer A, Nathansohn N, Kaplan B, Trau H. Toenail abnormalities and onychomycosis in chronic venous insufficiency of the legs: should we treat? J Eur Acad Dermatol Venereol. 2008;22:279–82.CrossRefPubMed
7.
Zurück zum Zitat Gupta AK, Gupta MA, Summerbell RC, et al. The epidemiology of onychomycosis: possible role of smoking and peripheral arterial disease. J Eur Acad Dermatol Venereol. 2000;14:466–9.CrossRefPubMed Gupta AK, Gupta MA, Summerbell RC, et al. The epidemiology of onychomycosis: possible role of smoking and peripheral arterial disease. J Eur Acad Dermatol Venereol. 2000;14:466–9.CrossRefPubMed
8.
Zurück zum Zitat Ginter-Hanselmayer G, Weger W, Smolle J. Onychomycosis: a new emerging infectious disease in childhood population and adolescents. Report on treatment experience with terbinafine and itraconazole in 36 patients. J Eur Acad Dermatol Venereol. 2008;22:470–5.CrossRefPubMed Ginter-Hanselmayer G, Weger W, Smolle J. Onychomycosis: a new emerging infectious disease in childhood population and adolescents. Report on treatment experience with terbinafine and itraconazole in 36 patients. J Eur Acad Dermatol Venereol. 2008;22:470–5.CrossRefPubMed
9.
Zurück zum Zitat Zisova L, Valtchev V, Sotiriou E, Gospodinov D, Mateev G. Оnychomycosis in patients with psoriasis—a multicenter study. Mycoses. 2011;55(2):143–7.PubMed Zisova L, Valtchev V, Sotiriou E, Gospodinov D, Mateev G. Оnychomycosis in patients with psoriasis—a multicenter study. Mycoses. 2011;55(2):143–7.PubMed
10.
Zurück zum Zitat Leibovici V, Heirshko K, Ingber A, Westerman M, Leviatan-Strauss N, Hoshberg M. Increased prevalence of onychomycosis among psoriatic patients in Israel. Acta Derm Venereol. 2008;88:31–3.CrossRefPubMed Leibovici V, Heirshko K, Ingber A, Westerman M, Leviatan-Strauss N, Hoshberg M. Increased prevalence of onychomycosis among psoriatic patients in Israel. Acta Derm Venereol. 2008;88:31–3.CrossRefPubMed
11.
Zurück zum Zitat Gupta AK, Lynde CW, Jain HC, et al. A higher prevalence of onychomycosis in psoriatics compared with non-psoriatics: a multicenter study. Br J Dermatol. 1997;136:786–9.CrossRefPubMed Gupta AK, Lynde CW, Jain HC, et al. A higher prevalence of onychomycosis in psoriatics compared with non-psoriatics: a multicenter study. Br J Dermatol. 1997;136:786–9.CrossRefPubMed
12.
Zurück zum Zitat Bristow IR, Spruce MC. Fungal foot infection, cellulitis and diabetes: a review. Diabet Med. 2009;26:548–51.CrossRefPubMed Bristow IR, Spruce MC. Fungal foot infection, cellulitis and diabetes: a review. Diabet Med. 2009;26:548–51.CrossRefPubMed
13.
Zurück zum Zitat Fletcher CL, Hay RJ, Smeeton NC. Observer agreement in recording the clinical signs of nail disease and the accuracy of a clinical diagnosis of fungal and non-fungal nail disease. Br J Dermatol. 2003;148:558–62.CrossRefPubMed Fletcher CL, Hay RJ, Smeeton NC. Observer agreement in recording the clinical signs of nail disease and the accuracy of a clinical diagnosis of fungal and non-fungal nail disease. Br J Dermatol. 2003;148:558–62.CrossRefPubMed
14.
Zurück zum Zitat Zaias N, Tosti A, Rebell G, et al. Autosomal dominant pattern of distal subungual onychomycosis caused by Trichophyton rubrum. J Am Acad Dermatol. 1996;34:302–4.CrossRefPubMed Zaias N, Tosti A, Rebell G, et al. Autosomal dominant pattern of distal subungual onychomycosis caused by Trichophyton rubrum. J Am Acad Dermatol. 1996;34:302–4.CrossRefPubMed
15.
Zurück zum Zitat Svejgaard EL, Nilsson J. Onychomycosis in Denmark: prevalence of fungal nail infection in general practice. Mycoses. 2004;47:131–5.CrossRefPubMed Svejgaard EL, Nilsson J. Onychomycosis in Denmark: prevalence of fungal nail infection in general practice. Mycoses. 2004;47:131–5.CrossRefPubMed
16.
Zurück zum Zitat Roujeau JC, Sigurgeirsson B, Korting HC, Kerl H, Paul C. Chronic dermatomycoses of the foot as risk factors for acute bacterial cellulitis of the leg: a case-control study. Dermatology. 2004;209:301–7.CrossRefPubMed Roujeau JC, Sigurgeirsson B, Korting HC, Kerl H, Paul C. Chronic dermatomycoses of the foot as risk factors for acute bacterial cellulitis of the leg: a case-control study. Dermatology. 2004;209:301–7.CrossRefPubMed
17.
Zurück zum Zitat Tchernev G, Cardoso JC, Ali MM, Patterson JW. Primary onychomycosis with granulomatous Tinea faciei. Braz J Infect Dis. 2010;14:546–7.PubMed Tchernev G, Cardoso JC, Ali MM, Patterson JW. Primary onychomycosis with granulomatous Tinea faciei. Braz J Infect Dis. 2010;14:546–7.PubMed
18.
Zurück zum Zitat Nenoff P, Mügge C, Herrmann J, Keller U. Tinea faciei incognito due to Trichophyton rubrum as a result of autoinoculation from onychomycosis. Mycoses. 2007;50 Suppl 2:20–5.CrossRefPubMed Nenoff P, Mügge C, Herrmann J, Keller U. Tinea faciei incognito due to Trichophyton rubrum as a result of autoinoculation from onychomycosis. Mycoses. 2007;50 Suppl 2:20–5.CrossRefPubMed
19.
Zurück zum Zitat Nenoff P, Wetzig T, Gebauer S, et al. Tinea barbae et faciei durch Trichophyton rubrum. Akt Dermatol. 1999;25:392–6. Nenoff P, Wetzig T, Gebauer S, et al. Tinea barbae et faciei durch Trichophyton rubrum. Akt Dermatol. 1999;25:392–6.
20.
Zurück zum Zitat Szepietowski JC, Reich A. Stigmatisation in onychomycosis patients: a population-based study. Мycoses. 2009;52:343–9.CrossRef Szepietowski JC, Reich A. Stigmatisation in onychomycosis patients: a population-based study. Мycoses. 2009;52:343–9.CrossRef
21.
Zurück zum Zitat Effendy I, Lecha M, Feuilhade de Chauvin M, Di Chiacchio N, Baran R. European onychomycosis observatory. Epidemiology and clinical classification of onychomycosis. J Eur Acad Dermatol Venereol. 2005;19 Suppl 1:8–12.CrossRefPubMed Effendy I, Lecha M, Feuilhade de Chauvin M, Di Chiacchio N, Baran R. European onychomycosis observatory. Epidemiology and clinical classification of onychomycosis. J Eur Acad Dermatol Venereol. 2005;19 Suppl 1:8–12.CrossRefPubMed
22.
Zurück zum Zitat Guibal F, Baran R, Duhard E, Feuilhade de Chauvin M. Epidemiology and management of onychomycosis in private dermatological practice in France. Ann Dermatol Venereol. 2008;135:561–6.CrossRefPubMed Guibal F, Baran R, Duhard E, Feuilhade de Chauvin M. Epidemiology and management of onychomycosis in private dermatological practice in France. Ann Dermatol Venereol. 2008;135:561–6.CrossRefPubMed
23.
Zurück zum Zitat Shemer A, Trau H, Davidovici B, Grunwald MH, Amichai B. Nail sampling in onychomycosis: comparative study of curettage from three sites of the infected nail. J Dtsch Dermatol Ges. 2007;5:1108–11.CrossRefPubMed Shemer A, Trau H, Davidovici B, Grunwald MH, Amichai B. Nail sampling in onychomycosis: comparative study of curettage from three sites of the infected nail. J Dtsch Dermatol Ges. 2007;5:1108–11.CrossRefPubMed
24.
Zurück zum Zitat Nenoff P, Ginter-Hanselmayer G, Tietz HJ. Fungal nail infections—an update: part 2—from the causative agent to diagnosis—conventional and molecular procedures. Hautarzt. 2012;63:130–8.CrossRefPubMed Nenoff P, Ginter-Hanselmayer G, Tietz HJ. Fungal nail infections—an update: part 2—from the causative agent to diagnosis—conventional and molecular procedures. Hautarzt. 2012;63:130–8.CrossRefPubMed
25.
Zurück zum Zitat Weinberg JM, Koestenblatt EK, Tutrone WD, Tishler HR, Najarian L. Comparison of diagnostic methods in the evaluation of onychomycosis. J Am Acad Dermatol 2003;49:193–7.CrossRefPubMed Weinberg JM, Koestenblatt EK, Tutrone WD, Tishler HR, Najarian L. Comparison of diagnostic methods in the evaluation of onychomycosis. J Am Acad Dermatol 2003;49:193–7.CrossRefPubMed
26.
Zurück zum Zitat Nenoff P, Ginter-Hanselmayer G, Tietz HJ. Fungal nail infections—an update: part 1—prevalence, epidemiology, predisposing conditions, and differential diagnosis. Hautarzt. 2012;63:30–8.CrossRefPubMed Nenoff P, Ginter-Hanselmayer G, Tietz HJ. Fungal nail infections—an update: part 1—prevalence, epidemiology, predisposing conditions, and differential diagnosis. Hautarzt. 2012;63:30–8.CrossRefPubMed
27.
Zurück zum Zitat El Fari M, Tietz H-J, Presber W, Sterry W, Gräser Y. Development of an oligonucleotide probe specific for Trichophyton rubrum. Br J Dermatol. 1999;141:240–5.CrossRefPubMed El Fari M, Tietz H-J, Presber W, Sterry W, Gräser Y. Development of an oligonucleotide probe specific for Trichophyton rubrum. Br J Dermatol. 1999;141:240–5.CrossRefPubMed
28.
Zurück zum Zitat Mügge C, Haustein UF, Nenoff P. Causative agents of onychomycosis—a retrospective study. J Dtsch Dermatol Ges. 2006;4:218–28.CrossRefPubMed Mügge C, Haustein UF, Nenoff P. Causative agents of onychomycosis—a retrospective study. J Dtsch Dermatol Ges. 2006;4:218–28.CrossRefPubMed
29.
Zurück zum Zitat Gräser Y, Scott J, Summerbell RC. The new species concept in dermatophytes—a polyphasic approach. Mycopathologia. 2008;166:239–56.CrossRefPubMed Gräser Y, Scott J, Summerbell RC. The new species concept in dermatophytes—a polyphasic approach. Mycopathologia. 2008;166:239–56.CrossRefPubMed
30.
Zurück zum Zitat Heidemann S, Monod M, Gräser Y. Signature polymorphisms in the internal transcribed spacer region relevant for the differentiation of zoophilic and anthropophilic strains of Trichophyton interdigitale and other species of T. mentagrophytes sensu lato. Br J Dermatol. 2010;162:282–95.CrossRefPubMed Heidemann S, Monod M, Gräser Y. Signature polymorphisms in the internal transcribed spacer region relevant for the differentiation of zoophilic and anthropophilic strains of Trichophyton interdigitale and other species of T. mentagrophytes sensu lato. Br J Dermatol. 2010;162:282–95.CrossRefPubMed
31.
Zurück zum Zitat Nenoff P, Mügge С, Haustein UF. Differenzierung der klinisch wichtigsten Dermatophyten. Teil I: Trichophyton. Derm Prakt Dermatol. 2002;8:16–31. Nenoff P, Mügge С, Haustein UF. Differenzierung der klinisch wichtigsten Dermatophyten. Teil I: Trichophyton. Derm Prakt Dermatol. 2002;8:16–31.
32.
Zurück zum Zitat Beifuss B, Bezold G, Gottlöber P, et al. Direct detection of five common dermatophyte species in clinical samples using a rapid and sensitive 24-h PCR-ELISA technique open to protocol transfer. Mycoses. 2011;54:137–45.CrossRefPubMed Beifuss B, Bezold G, Gottlöber P, et al. Direct detection of five common dermatophyte species in clinical samples using a rapid and sensitive 24-h PCR-ELISA technique open to protocol transfer. Mycoses. 2011;54:137–45.CrossRefPubMed
33.
Zurück zum Zitat Brillowska-Dabrowska A, Saunte DM, Arendrup MC. Five-hour diagnosis of dermatophyte nail infections with specific detection of Trichophyton rubrum. J Clin Microbiol. 2007;45:1200–4.CrossRefPubMed Brillowska-Dabrowska A, Saunte DM, Arendrup MC. Five-hour diagnosis of dermatophyte nail infections with specific detection of Trichophyton rubrum. J Clin Microbiol. 2007;45:1200–4.CrossRefPubMed
34.
Zurück zum Zitat Nenoff P, Herrmann J, Gräser Y. Trichophyton mentagrophytes sive interdigitale? Ein dermatophyt im wandel der zeit. J Dtsch Dermatol Ges. 2007;5:198–203.CrossRefPubMed Nenoff P, Herrmann J, Gräser Y. Trichophyton mentagrophytes sive interdigitale? Ein dermatophyt im wandel der zeit. J Dtsch Dermatol Ges. 2007;5:198–203.CrossRefPubMed
35.
Zurück zum Zitat Kallow W, Erhard M, Shah H, Raptakis E, Welker M. Chapter 12—MALDI-TOF MS for microbial identification: years of experimental development to an established protocol. In: Shah H, Gharbia S, Encheva V, editors. Mass spectrometry for microbial proteomics. Chichester:Wiley; 2010. pp. 255–76. ISBN:978-0-470-68199-2.CrossRef Kallow W, Erhard M, Shah H, Raptakis E, Welker M. Chapter 12—MALDI-TOF MS for microbial identification: years of experimental development to an established protocol. In: Shah H, Gharbia S, Encheva V, editors. Mass spectrometry for microbial proteomics. Chichester:Wiley; 2010. pp. 255–76. ISBN:978-0-470-68199-2.CrossRef
36.
Zurück zum Zitat Stackebrandt E, Päuker О, Erhard М. Grouping myxococci (Corallococcus) strains by matrix-assisted laser desorption Ionization time-of-flight (MALDI TOF) mass spectrometry: comparison with gene sequence phylogenies. Curr Microbiol. 2005;50:71–7.CrossRefPubMed Stackebrandt E, Päuker О, Erhard М. Grouping myxococci (Corallococcus) strains by matrix-assisted laser desorption Ionization time-of-flight (MALDI TOF) mass spectrometry: comparison with gene sequence phylogenies. Curr Microbiol. 2005;50:71–7.CrossRefPubMed
37.
Zurück zum Zitat Donohue MJ, Smallwood АW, Pfaller S, Rodgers M, Shoemaker JA. The development of a matrix-assisted laser desorption/ionization mass spectrometry-based method for the protein fingerprinting and identification of Aeromonas species using whole cells. J Microbiol Methods. 2006;65:380–9.CrossRefPubMed Donohue MJ, Smallwood АW, Pfaller S, Rodgers M, Shoemaker JA. The development of a matrix-assisted laser desorption/ionization mass spectrometry-based method for the protein fingerprinting and identification of Aeromonas species using whole cells. J Microbiol Methods. 2006;65:380–9.CrossRefPubMed
38.
Zurück zum Zitat Donohue MJ, Best JM, Smallwood AW, Kostich M, Rodgers M, Shoemaker JA. Differentiation of Aeromonas isolated from drinking water distribution systems using matrix-assisted laser desorption/ionization-mass spectrometry. Anal Chem. 2007;79:1939–46.CrossRefPubMed Donohue MJ, Best JM, Smallwood AW, Kostich M, Rodgers M, Shoemaker JA. Differentiation of Aeromonas isolated from drinking water distribution systems using matrix-assisted laser desorption/ionization-mass spectrometry. Anal Chem. 2007;79:1939–46.CrossRefPubMed
39.
Zurück zum Zitat Pignone M, Greth KM, Cooper J, Emerson D, Tang J. Identification of mycobacteria by matrix-assisted laser desorption ionization-time-of-flight mass spectrometry. J Clin Microbiol. 2006;44:1963–70.CrossRefPubMed Pignone M, Greth KM, Cooper J, Emerson D, Tang J. Identification of mycobacteria by matrix-assisted laser desorption ionization-time-of-flight mass spectrometry. J Clin Microbiol. 2006;44:1963–70.CrossRefPubMed
40.
Zurück zum Zitat Erhard M, Hipler UC. SARAMIS-MALDI-TOF MS analysis of Aspergillus species. Mycoses. 2007;50:352 (abstract). Erhard M, Hipler UC. SARAMIS-MALDI-TOF MS analysis of Aspergillus species. Mycoses. 2007;50:352 (abstract).
41.
Zurück zum Zitat Pföhler C, Hollemeyer K, Heinzle Е, Altmeyer W, Graeber S, Müller CS, Stark A, Jager SU, Tilgen W. Matrix-assisted laser desorption/ionization time-of-flight mass spectrometry: a new tool in diagnostic investigation of nail disorders? Exp Dermatol. 2009;18:880–2.CrossRefPubMed Pföhler C, Hollemeyer K, Heinzle Е, Altmeyer W, Graeber S, Müller CS, Stark A, Jager SU, Tilgen W. Matrix-assisted laser desorption/ionization time-of-flight mass spectrometry: a new tool in diagnostic investigation of nail disorders? Exp Dermatol. 2009;18:880–2.CrossRefPubMed
42.
Zurück zum Zitat Lecha M, Effendy I, Feuilhade de Chauvin M, Di Chiacchio N, Baran R. Taskforce on onychomycosis education. Treatment options-development of consensus guidelines. J Eur Acad Dermatol Venereol. 2005;19 Suppl 1:25–33.CrossRefPubMed Lecha M, Effendy I, Feuilhade de Chauvin M, Di Chiacchio N, Baran R. Taskforce on onychomycosis education. Treatment options-development of consensus guidelines. J Eur Acad Dermatol Venereol. 2005;19 Suppl 1:25–33.CrossRefPubMed
43.
Zurück zum Zitat Nenoff P. Mykologie—state of the art. Kompendium Dermatol. 2010;6(1):1–3. Nenoff P. Mykologie—state of the art. Kompendium Dermatol. 2010;6(1):1–3.
44.
Zurück zum Zitat Gupta AK, Lynch LE, Kogan N, Cooper EA. The use of an intermittent terbinafine regimen for the treatment of dermatophyte toenail onychomycosis. J Eur Acad Dermatol Venereol. 2009;23:256–62CrossRefPubMed Gupta AK, Lynch LE, Kogan N, Cooper EA. The use of an intermittent terbinafine regimen for the treatment of dermatophyte toenail onychomycosis. J Eur Acad Dermatol Venereol. 2009;23:256–62CrossRefPubMed
45.
Zurück zum Zitat Zisova L. Fluconazole in the treatment of onychomycosis. Folia Medica. 2004;46:47–50.PubMed Zisova L. Fluconazole in the treatment of onychomycosis. Folia Medica. 2004;46:47–50.PubMed
46.
Zurück zum Zitat Gupta AK, Drummond-Main C, Cooper EA, Brintnell W, Piraccini BM, Tosti A. Systematic review of nondermatophyte mold onychomycosis: diagnosis, clinical types, epidemiology, and treatment. J Am Acad Dermatol. 2012;66:494–502.CrossRefPubMed Gupta AK, Drummond-Main C, Cooper EA, Brintnell W, Piraccini BM, Tosti A. Systematic review of nondermatophyte mold onychomycosis: diagnosis, clinical types, epidemiology, and treatment. J Am Acad Dermatol. 2012;66:494–502.CrossRefPubMed
47.
Zurück zum Zitat Ling MR, Swinyer LJ, Jarrat MT, et al. Once weekly fluconazole (450 mg) for 4, 6 or 9 months of treatment for distal subungual onychomycosis of the toe nail. J Am Acad Dermotol. 1998;38(6 Pt 2):S95–102.CrossRef Ling MR, Swinyer LJ, Jarrat MT, et al. Once weekly fluconazole (450 mg) for 4, 6 or 9 months of treatment for distal subungual onychomycosis of the toe nail. J Am Acad Dermotol. 1998;38(6 Pt 2):S95–102.CrossRef
48.
Zurück zum Zitat Baran R, Hay RJ. Partial surgical avulsion of the nail in onychomycosis. Clin Exp Dermatol. 1985;10:413–8.CrossRefPubMed Baran R, Hay RJ. Partial surgical avulsion of the nail in onychomycosis. Clin Exp Dermatol. 1985;10:413–8.CrossRefPubMed
49.
Zurück zum Zitat Lai WY, Tang WY, Loo SK, Chan Y. Clinical characteristics and treatment outcomes of patients undergoing nail avulsion surgery for dystrоphic nails. Hong Kong Med J. 2011;17:127–31.PubMed Lai WY, Tang WY, Loo SK, Chan Y. Clinical characteristics and treatment outcomes of patients undergoing nail avulsion surgery for dystrоphic nails. Hong Kong Med J. 2011;17:127–31.PubMed
50.
Zurück zum Zitat Hochman LG. Laser treatment of onychomycosis using a novel 0.65-millisecond pulsed Nd:YAG 1064-nm laser. J Cosmеt Las Ther. 2011;13:2–5.CrossRef Hochman LG. Laser treatment of onychomycosis using a novel 0.65-millisecond pulsed Nd:YAG 1064-nm laser. J Cosmеt Las Ther. 2011;13:2–5.CrossRef
51.
Zurück zum Zitat Landsman AS, Robbins AH, Angelini PF, et al. Treatment of mild, moderate, and severe onychomycosis using 870- and 930 nm light exposure. J Am Podiatr Med Assoc. 2010;100:166–77.PubMed Landsman AS, Robbins AH, Angelini PF, et al. Treatment of mild, moderate, and severe onychomycosis using 870- and 930 nm light exposure. J Am Podiatr Med Assoc. 2010;100:166–77.PubMed
52.
Zurück zum Zitat Manevitch Z, Lev D, Hochberg M, Palhan M, Lewis A, Enk CD. Direct antifungal effect of femtosecond laser on Trichophyton rubrum onychomycosis. Photochem Photobiol. 2010;86:476–9.CrossRefPubMed Manevitch Z, Lev D, Hochberg M, Palhan M, Lewis A, Enk CD. Direct antifungal effect of femtosecond laser on Trichophyton rubrum onychomycosis. Photochem Photobiol. 2010;86:476–9.CrossRefPubMed
53.
Zurück zum Zitat Borovoy M, Tracy M. Noninvasive CO2 laser fenestration improves treatment of onychomycosis. Clin Laser Mon. 1992;10:123–4.PubMed Borovoy M, Tracy M. Noninvasive CO2 laser fenestration improves treatment of onychomycosis. Clin Laser Mon. 1992;10:123–4.PubMed
54.
Zurück zum Zitat Rothermel E, Apfelberg DB. Carbon dioxide laser use for certain diseases of the toenails. Clin Podiatr Med Surg. 1987;4:809–21.PubMed Rothermel E, Apfelberg DB. Carbon dioxide laser use for certain diseases of the toenails. Clin Podiatr Med Surg. 1987;4:809–21.PubMed
55.
56.
Zurück zum Zitat Aspiroz C, Fortuño Cebamanos B, Rezusta A, Paz-Cristóbal P, Domínguez-Luzón F, Gené Díaz J, Gilaberte Y. Photodynamic therapy for onychomycosis. Case report and review of the literature. Rev Iberoam Micol. 2011;28:191–3.CrossRefPubMed Aspiroz C, Fortuño Cebamanos B, Rezusta A, Paz-Cristóbal P, Domínguez-Luzón F, Gené Díaz J, Gilaberte Y. Photodynamic therapy for onychomycosis. Case report and review of the literature. Rev Iberoam Micol. 2011;28:191–3.CrossRefPubMed
57.
Zurück zum Zitat Kamp H, Tietz HJ, Lutz M, Piazena H, Sowyrda P, Lademann J, Blume-Peytavi U. Antifungal effect of 5-aminolevulinic acid PDT in Trichophyton rubrum. Mycoses. 2005;48:101–7.CrossRefPubMed Kamp H, Tietz HJ, Lutz M, Piazena H, Sowyrda P, Lademann J, Blume-Peytavi U. Antifungal effect of 5-aminolevulinic acid PDT in Trichophyton rubrum. Mycoses. 2005;48:101–7.CrossRefPubMed
58.
Zurück zum Zitat Gilaberte Y, Aspiroz C, Martes MP, Alcalde V, Espinel-Ingroff A, Rezusta A. Treatment of refractory fingernail onychomycosis caused by nondermatophyte molds with methylaminolevulinate photodynamic therapy. J Am Acad Dermatol. 2011;65:669–71.CrossRefPubMed Gilaberte Y, Aspiroz C, Martes MP, Alcalde V, Espinel-Ingroff A, Rezusta A. Treatment of refractory fingernail onychomycosis caused by nondermatophyte molds with methylaminolevulinate photodynamic therapy. J Am Acad Dermatol. 2011;65:669–71.CrossRefPubMed
59.
Zurück zum Zitat Watanabe D, Kawamura C, Masuda Y, Akita Y, Tamada Y, Matsumoto Y. Successful treatment of toenail onychomycosis with photodynamic therapy. Arch Dermatol. 2008;144:19–21.CrossRefPubMed Watanabe D, Kawamura C, Masuda Y, Akita Y, Tamada Y, Matsumoto Y. Successful treatment of toenail onychomycosis with photodynamic therapy. Arch Dermatol. 2008;144:19–21.CrossRefPubMed
60.
Zurück zum Zitat Sotiriou E, Koussidou-Eremonti T, Chaidemenos G, Apalla Z, Ioannides D. Photodynamic therapy for distal and lateral subungual toenail onychomycosis caused by trichophyton rubrum: preliminary results of a single-centre open trial. Acta Derm Venereol. 2010;90:216–7.CrossRefPubMed Sotiriou E, Koussidou-Eremonti T, Chaidemenos G, Apalla Z, Ioannides D. Photodynamic therapy for distal and lateral subungual toenail onychomycosis caused by trichophyton rubrum: preliminary results of a single-centre open trial. Acta Derm Venereol. 2010;90:216–7.CrossRefPubMed
61.
Zurück zum Zitat Petranyi G, Ryder NS, Stutz A. Allylamine derivatives: new class of synthetic antifungal agents inhibiting fungal squalene epoxidase. Science. 1984;224:1239–41.CrossRefPubMed Petranyi G, Ryder NS, Stutz A. Allylamine derivatives: new class of synthetic antifungal agents inhibiting fungal squalene epoxidase. Science. 1984;224:1239–41.CrossRefPubMed
62.
Zurück zum Zitat Ryder NS, Favre B. Antifungal activity and mechanism of action of terbinafine. Rev Contemp Pharmacother. 1997;8:275–87. Ryder NS, Favre B. Antifungal activity and mechanism of action of terbinafine. Rev Contemp Pharmacother. 1997;8:275–87.
63.
Zurück zum Zitat Ryder NS, Wagner S, Leitner I. In vitro activities of terbinafine against cutaneous isolates of Candida albicans and other pathogenic yeasts. Antimicrob Agents Chemother. 1998;42:1057–61.PubMed Ryder NS, Wagner S, Leitner I. In vitro activities of terbinafine against cutaneous isolates of Candida albicans and other pathogenic yeasts. Antimicrob Agents Chemother. 1998;42:1057–61.PubMed
Metadaten
Titel
Onychomycosis: modern diagnostic and treatment approaches
verfasst von
Assoc. Prof. Georgi Tchernev
Plamen Kolev Penev, MD
Prof. Dr. med. Pietro Nenoff
Assoc. Prof. Liliya Georgieva Zisova, MD, PhD
José Carlos Cardoso
Dr. Teodora Taneva
Assoc. Prof. Gabriele Ginter-Hanselmayer, MD
Julian Ananiev
Assoc. Prof. Maya Gulubova, MD, PhD
Reni Hristova, MD
Desislava Nocheva, MD
Claudio Guarneri, MD
A.O.U. G. Martino
Nobuo Kanazawa, MD, PhD
Publikationsdatum
01.01.2013
Verlag
Springer Vienna
Erschienen in
Wiener Medizinische Wochenschrift / Ausgabe 1-2/2013
Print ISSN: 0043-5341
Elektronische ISSN: 1563-258X
DOI
https://doi.org/10.1007/s10354-012-0139-3

Weitere Artikel der Ausgabe 1-2/2013

Wiener Medizinische Wochenschrift 1-2/2013 Zur Ausgabe